top of page
Browse by category
Search


GLP-1 drugs benefit children who are living with severe obesity
Children who are living with severe obesity are more likely to experience a clinically relevant change in BMI when GLP-1 agonist drugs...


GLP-1s cut alcohol intake by almost two-thirds
Individuals who take liraglutide or semaglutide for weight loss reduced their alcohol consumption by almost two-thirds in four months,...


GLP-s are safe and effective for treating obesity in adults with mental illness
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with...


Women more likely to be aware of and have good understanding of obesity drugs
Women are much more aware of and knowledgeable about the obesity drugs GLP-1/GIP receptor agonists (that include semaglutide and...


GLP-1ras show anti-cancer benefits beyond weight loss
First generation weight-loss medications like liraglutide and exenatide appear to show anti-cancer benefits beyond weight loss. Indeed,...


GLP-1s post-bariatric surgery offer additional cardiovascular benefits
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) may help to reduce the risk of heart attacks, strokes, and other major adverse...


GLP-1 therapies have potential to treat Bardet-Biedl syndrome
A Monell Chemical Senses Center study has identified that GLP-1 receptor agonists as a promising therapeutic for managing the metabolic...


Sharp rise in use of new GLPs as metformin, sulfonylureas and insulin declines
Investigators from Mass General Brigham who examined claims data from nearly two million people between 2021 and 2023, have reported a...


Biolexis reveals allosteric activation mechanism for the GLP-1 receptor
Biolexis Therapeutics has achieved a transformative milestone in metabolic drug discovery with the successful resolution of the...


GLP-1 receptor agonists target fat over muscle for weight loss
A research team from the School of Public Health, in the LKS Faculty of Medicine of the University of Hong Kong (HKUMed), who assessed...
Browse by tag






bottom of page